Tranexamic Acid and Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)

Clinical trial NCT01031992 · COMPLETED

Trial details

NCT number: NCT01031992
Sponsor: University Hospital, Saarland
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Hemorrhagic Telangiectasia

Start date: 2002-03-01
Primary completion: 2002-08-01
Enrollment: 23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.